Introduction
Eucaryotic cells maintain genomic integrity by monitoring DNA for damage or incomplete replication. In the event of aberrant DNA structures being detected, cells activate regulatory pathways to delay cell-cycle progression and to allow the damage to be repaired or replication to be completed (Abraham, 2001) . Cells can also activate pathways leading to apoptosis and the removal of a damage cell from a tissue. The balance between the two pathways determines the survival of individual cells and the maintenance of genomic stability. Mammalian cells have two protein kinases of the phosphoinositide 3-kinase-related kinase family, ataxia telangiectasia mutated (ATM) kinase and ATMRad3-related kinase (ATR), which play central roles in sensing and responding to chromosomal insults (Abraham, 2001) . Downstream of ATM and ATR kinases are the cell-cycle checkpoint kinases (Chk)1 and Chk2, activation of which requires the mediator family of proteins such as Claspin and BRCA1.
DNA replication stress occurring in S phase triggers activation of ATR that phosphorylates Chk1 at Ser317 and Ser345 and upregulates its kinase activity (Abraham, 2001; Chen and Sanchez, 2004) . Activated Chk1 inhibits the protein phosphatase Cdc25A and Cdc25C by phosphorylation, halting ongoing DNA replication and initiating DNA repair. Cdc25A and Cdc25C control inhibitory phosphorylation sites on cyclin-dependent kinases (cdks), critical regulators of cell-cycle transitions (Walworth et al., 1993; Sanchez et al., 1997) . As Chk1 has a critical role in maintaining genomic stability, Chk1 inactivation in somatic cells results in accumulation of structural chromosomal aberrations, eventually leading to tumorigenesis (Kastan and Bartek, 2004; Lam et al., 2004) . Consistently, study of Chk1 knockout mice shows that Chk1 is a haploinsufficient tumor suppressor gene (Lam et al., 2004) . p27 Kip1 , a cdk inhibitor, is a rate-determining component of cell-cycle exit in a number of cell types and plays a key role in coordinating the activity of cyclin E-cdk2 with accumulation of cyclin D-cdk4 (Nakayama et al., 2004) . The amount of p27 increases in quiescent cells, whereas mitogens and extracellular matrix adhesion signals can promote p27 degradation, allowing quiescent cells to re-enter the cell-cycle. Consistent with a role for p27 in cell proliferation, p27 knockout mice develop hyperplasia in multiple organs but are relatively free from malignancy with the exception of pituitary hyperplasia (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Thus, p27 might act as a weak tumor suppressor of a narrowly defined group of cells, largely the decision of cells to exit the cell-cycle (Fero et al., 1998; Di Cristofano et al., 2001) .
Bcl11b/Rit1/Ctip2 is a tumor suppressor gene isolated by positional cloning using g-ray-induced mouse thymic lymphomas (Shinbo et al., 1999; Wakabayashi et al., 2003a; Sakata et al., 2004) . Recurrent chromosomal rearrangements at BCL11B locus are also found in human T-cell leukemias (Nagel et al., 2003; Przybylski et al., 2005) . Bcl11b encodes a member of the zinc-finger proteins (Avram et al., 2000; Satterwhite et al., 2001; Wakabayashi et al., 2003a) and directly interacts with Sirt1, a member of a third class of Trichostatin-resistant deacetylase, and with the nucleosome remodeling and histone deacetylase complex, one of the major transcriptional corepressor complexes in mammalian cells (Senawong et al., 2003; Cismasiu et al., 2005) . However, target genes or genes controlled by Bcl11b are not known. Bcl11b À/À mice die soon after birth, exhibiting the developmental arrest of thymocytes of the ab T-cell lineage (Wakabayashi et al., 2003b (Inoue et al., 2006) . At the DN4 stage, thymocytes re-enter into the cell-cycle and rapidly proliferate (Gounari et al., 2001; van de Wetering et al., 2002) . As apoptosis has been considered as a mechanism to eliminate deleterious cells, the apoptotic phenotype of Bcl11b À/À thymocytes seems to contradict with Bcl11b as a tumor suppressor.
This article examines Bcl11b-lacking cells in vitro and in vivo to elucidate how the apoptosis conferred by Bcl11b deficiency contributes to tumor development. Here, we show growth stimulation-dependent apoptosis and Chk1 deregulation in those cells, suggesting a role of Bcl11b in the remedy for stress during DNA replication and maintenance of genomic stability.
Results
Growth suppression and apoptosis of Bcl11b-KD cells Bcl11b knockdown (KD) lines were produced by transfecting plasmid DNA expressing two different short interfering RNA (siRNA) sequences into Jurkat cells, a human T-cell lymphoma line. Figure 1a shows Western blots of three KD cell lines derived from transfectants using one siRNA and Supplementary Figure S1 shows those of the other. Marked decrease in the Bcl11b expression was seen in KD lines (si-1, -2, -3), compared with two control cell lines (sc-1, -2) that were obtained with plasmid DNA expressing scramble RNA sequences. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed repression of cell growth in all KD lines relative to control lines under the condition of 10% serum supplementation, whereas such difference was not observed at 5 or 1% serum concentration (Figure 1b) . Analyses of apoptosis in 10% serum-supplemented KD cells displayed elevated proportions of Annexin V-positive cells ( Figure 1c ) and terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) staining-positive cells (Figure 1d ). Consistently, cleavage of caspase-7 and decrease in expression of an antiapoptotic protein, BclxL (Motoyama et al., 1995) , were detected ( Figure 1a ).
This apoptotic phenotype is consistent with that in Bcl11b
À/À mouse thymocytes (Wakabayashi et al., 2003b; Inoue et al., 2006) and may contrast with the current notion that apoptosis is reduced when tumor suppressor gene is lost.
We examined cell cycling after the release from double-thymidine block. At 10% serum concentration, most cells entered into S phase 6 h after the release but KD cells showed some delay in cell-cycle progression. It was noted that the number of the S phase cells was much lower in KD cells than control cells, whereas the number of sub-G1 phase cells was higher (Figure 1e ). This suggests the abrogation of S phase checkpoint in KD cells and resulting apoptosis of some KD cells. On the other hand, analysis at 5% serum concentration revealed slowing down of cell-cycle progression in both KD and control cell lines. Of note is that no sub-G1 cells were detected in KD cells, indicating absence of apoptosis ( Figure 1e ). These results indicate that at 10% serum concentration, Bcl11b down regulation causes inhibition of cell growth owing to apoptosis and implicate the Bcl11b gene in S phase checkpoint.
S phase damage response DNA replication and UV-induced DNA damages generate single-stranded DNA (ssDNA), which serves as the signal for S phase checkpoint (Zou and Elledge, 2003) . We thus examined the effect on cell growth and cell cycling of KD cells after treatment with UV. We also examined effects of Camptothecin, an inhibitor of topoisomerase I and g-ray. Camptothecin produces both ssDNA and double-stranded DNA breaks (DSBs), whereas g-ray generates DSBs (Kastan and Bartek, 2004; Flatten et al., 2005) . At 10% serum concentration, UV and Camptothecin-inhibited cell growth more markedly for KD cells, whereas ionizing radiation inhibited both KD cells and control cells equally (Figure 2a) . The sub-G1 fraction was increased in KD cells over control cells after UV and Camptothecin treatments whereas the levels of the increase were similar for control and KD cells when exposed to g-rays (Figure 2b) .
Cell-cycle analysis of control cells showed persistence in the number of S phase cells 3 h after UV irradiation, indicating arrest in the cell-cycle progression (Figure 2c ). In contrast, a decrease of S phase cells was observed in KD cells. These indicated impaired activation of S phase checkpoint and enhanced apoptotic response in 10% serum-supplemented KD cells.
Impairment of Chk1 phosphorylation
The ssDNA damages activate ATR and its downstream checkpoint kinases, Chk1 and Chk2 (Liu et al., 2000; Abraham, 2001) . We thus examined these checkpoint kinases in 10% serum-supplemented KD cells before and after UV irradiation. Figure 3a shows examples of Western blotting and Figure 3b summarizes the results. Expression of Chk1 protein did not differ between control and KD cells, and UV irradiation did not affect their protein expression. However, the phosphorylation level of Chk1 was very low in KD cells, and UV irradiation did not elevate the phosphorylation level as did in control cells. Cdc25A, a substrate of Chk1 (Zhao et al., 2002) , showed a high expression in KD cells, indicating the inhibition of degradation owing to Chk1 impairment. On the other hand, expression and phosphorylation levels of Chk2 did not differ between KD and control cells and were not affected by UV irradiation. These results indicated Bcl11b downregulation resulting in the impairment of Chk1 phosphorylation No treatment The sc-1 and si-2 cells were treated with the TdT enzyme and stained with dUTP-fluorescein isothiocyanate using a TUNEL staining kit (Takara Inc., Japan), counterstained with 4 0 ,6-diamidino-2-phenylindole, dihydrochloride. (e) Cell-cycle analysis of cells at indicated times after the release from double thymidine block. The numbers of S phase cells 6 h after the release decreases in 10% serum-supplemented KD cells whereas the numbers of sub-G1 phase cells increases. In 5% serumsupplemented cells, the number of S phase cells 8 h after the release decreases but the number of sub-G1 phase cells does not increase.
Bcl11b regulates DNA damage and replication stress K Kamimura et al The phosphorylation level of Chk1 at Ser317 increases 6 h after administration of Camptothecin in control cells (sc-1 and sc-2) but not in KD cells (si-1 and si-2). Also, the phosphorylation level of Chk2 does not increase in si-1 and si-2 cells in response to UV irradiation. On the other hand, exposure of si-1 and si-2 cells to g-ray affects the phosphorylation of Chk2 but not Chk1. Collectively, impairment in Chk1 phosphorylation only is seen for UV irradiation, impairment in the phosphorylation of both Chk1 and Chk2 is seen for Camptothecin treatment and impairment in Chk2 phosphorylation only is seen for g-ray irradiation.
Bcl11b regulates DNA damage and replication stress K Kamimura et al under this culture condition. However, UV irradiation did not increase the Chk1 phosphorylation in KD cells. This suggests that the Bcl11b-lacking state provides a latent defect in S phase checkpoint which is revealed by growth stimuli and/or UV irradiation. Figure 3e shows effect of Camptothecin and g-irradiation. Administration of Camptothecin in KD cells exhibited impairment of phosphorylation for both Chk1 and Chk2 probably owing to generation of ssDNA and DSBs whereas the impairment was seen only for Chk2 after g-ray producing DSBs. The results revealed inability of Bcl11b-KD cells to activate both Chk1 and Chk2 in response to DNA-damaging agents. Among other proteins involved in ATR/Chk1 signaling pathway, expression of Claspin was found to decrease in 10% serum-supplemented KD cells (Supplementary Figure S2) . As Claspin is required for activation of Chk1 by ATR , this decrease may be relevant for reduced phosphorylation of Chk1 in KD cells.
Apoptosis, deregulated cell-cycle checkpoint and Sirt1 connection Recently, Clarke et al. (2005) reported that Claspin is a specific substrate of caspase-7 and cleaved during the initiation of genotoxic stress-induced apoptosis and that the Claspin processing regulates Chk1 activity. Accordingly, the Claspin cleavage may account for our finding of impaired Chk1 phosphorylation in 10% serumsupplemented KD cells. We thus performed Western blotting of caspase-7, Claspin, Chk1 in KD cells harvested at various times after shifting from 5 to 10% serum. Also, Bcl-xL and p27 were examined, because the serum elevation triggers cell-cycle progression regulated by p27 (Nakayama et al., 2004) . The cleavage of caspase-7 was noted 3 h after the shift, followed by the degradation of Claspin and decrease of phosphorylated Chk1 (Figure 4a ). This suggests a cascade of the activation of caspase-7, cleavage of Claspin and the inactivation of Chk1 kinase, consistent with that by Clarke et al. (2005) . On the other hand, the amount of Bcl-xL was low to start with but markedly decreased 6 h after. p27 expression was also low in KD cells, though unexpectedly high in control Jurkat cells, and markedly decreased 3 h after. The p27 reduction probably results in a rapid G1 progression that may contribute to apoptosis under the low concentration of Bcl-xL.
Elevation of the serum concentration triggers PI3K/ Akt kinase signaling and affects Sirt1 activity that associates with Bcl11b (Levine et al., 2006) . Thus, we examined Akt and Sirt1 by Western blotting (Figure 4b Sirt1 affects expression of a Foxo3a-target gene, p27, at the transcription level (Brunet et al., 2004; Motta et al., 2004) . As Sirt1 proteins decreased in 10% serumsupplemented KD cells, we examined mRNA expression of p27 and other genes presumably regulated by Foxo3a and Sirt1 in KD cells at various times after the serum shift. Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) showed that the mRNA level of p27 decreased in KD cells 3 h after whereas the expression of Bcl-xL was low to start with and gradually decreased up to 24 h (Figure 4c) . However, the levels of other possible Foxo3a-targets, Bim and Gadd45, were not affected. These suggest that growth stimulation by the serum elevation provides transcriptional repression of p27 and Bcl-xL in Bcl11b KD cells but not in control Bcl11b-proficient cells.
Examination of cell line specificity
To test whether the Chk1 activation by Bcl11b is cellline specific, we produced the FRSK skin keratinocyte cell line (tet-1) that expressed Bcl11b siRNA driven by a tetracycline/doxycycline inducible promoter. Western blotting showed a decrease in the expression of Bcl11b in tet-1 cells after addition of doxycycline but not in a control cell line (c-1) that was obtained by using plasmid DNA expressing scramble RNA sequences (Figure 5a ). MTT assay exhibited repression of cell growth in the tet-1 cells in the presence of doxycycline (open circles) (Figure 5b ). UV irradiation enhanced the growth repression, as in Bcl11b-KD Jurkat cells. Western blots showed a minimal decrease in Chk1 phosphorylation in the tet-1 cells with doxycycline but the decrease was prominent after UV irradiation (Figure 5a ). The Bcl11b downregulation and UV irradiation also seemed to affect Chk2 and its phosphorylation but those effects were not marked. These results showed that the suppression of Chk1 phosphorylation by Bcl11b downregulation was also detected in FRSK cells.
Next, we examined mouse thymocytes in vivo.
À/À mice were incubated in the culture medium, irradiated with UV and examined for protein expression 18 h after. Figure 6a shows examples of Western blotting and Figure 6b summarizes the results. Reduced expression of p27 was observed in Bcl11b À/À thymocytes and the expression was restored to the control level by UV irradiation. The cleavage of Claspin was seen in Bcl11b À/À thymocytes and was enhanced by UV irradiation. On the other hand, protein levels of Chk1 or Chk2 did not differ in thymocytes between the three different Bcl11b genotypes, nor were they affected by UV irradiation. However, Bcl11b deficiency reduced phosphorylation of Chk1 at the S317 and S345 positions and also phosphorylation of Chk2. In addition, UV-induced phosphorylation of Chk1 much less in Bcl11b À/À thymocytes than in control thymocytes. Fivefold amount of protein extracts from irradiated Bcl11b À/À thymocytes allowed us to detect phospholylated Chk1. On the other hand, UV irradiation-induced phosphorylation of Chk2 in thymocytes of all the three different genotypes. p53
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proteins in Bcl11b
À/À thymocytes increased in response to UV irradiation. These results indicate that Bcl11b downregulation or deficiency leads to decrease of p27 and suppression of Chk1 phosphorylation both in vitro and in vivo.
Discussion
This paper shows that Bcl11b-KD T-cell lines, when exposed to growth stimuli or UV radiation, exhibited extensive apoptosis with concomitant decreases in p27 and Bcl-xL. Also, deregulation of Chk1 phosphorylation was observed in the KD cells and Bcl11b À/À thymocytes after UV irradiation. These implicate Bcl11b in resisting DNA replication stress or DNA damages, although it is not clear how Bcl11b remedies these stresses. Bcl11b directly interacts with Sirt1 deacetylase (Senawong et al., 2003) , and hence the Bcl11b deficiency may affect some Sirt1 activity. In fact, the amount of Sirt1 decreased in Bc11b-KD cells relative to parental Jurkat cells where most Bcl11b proteins were localized at the chromatin. Sirt1 downregulates Foxo transcription factors but does not regulate all Foxo target genes in the same manner in different cellular contexts, because target genes such as p27 and Gadd45 are upregulated by Sirt1 in Foxo3a-expressing fibroblasts whereas another target of Bim gene is not affected (Brunet et al., 2004; Motta et al., 2004) . Similar differential regulation was observed for Bcl11b in Jurkat cells. In 10% serum-supplemented Bcl11b-KD cells, p27 expression decreased whereas expression of Bim or Gadd45 was not affected. In addition, decreased expression of Bcl-xL was observed in those cells. Therefore, Bcl11b may affect a subset of Foxo target genes through Sirt1 activity, and these affected genes overlap with but are different from those of Sirt1 in the absence of Bcl11b. Activity of the Foxo factors is not only regulated through acetylation but also through phosphorylation by Akt (Levine et al., 2006) . However, this possibility is less likely in KD cells because the phosphorylation level of Akt did not increase in response to growth factor activation. Collectively, decreases in p27 and Bcl-xL might account for all the enhanced apoptosis associated with Bcl11b deficiency. Western blots of cells harvested at indicated times after changing the medium containing 5%-10% serum. Cleavage of procaspase-7 is noted 3 h after the change, and decreases in Claspin and phosphorylated Chk1 at Ser317 are seen 6 h after. Bcl-xL is low at the beginning and markedly decreases 3-6 h after and p27 decrease starts at 2 h after. (b) Western blots of Akt, Sirt1, Mta1 and p27 in 10 and 5% serum-supplemented cells. Expression or phosphorylation level of Akt on the mammalian target of rapamycin signaling pathway does not change. Expression levels of Sirt1, Mta1 and p27 proteins are lower in si-1 cells than sc-1 cells in the medium containing 10% serum. The difference is much less in that containing 5% serum. (c) RT-PCR analysis of cells harvested at indicated times after the medium change. The mRNA amount of p27 rapidly decreases 3 h after whereas that of Bcl-xL is low at the beginning and gradually decreases until 24 h after. No change is seen in Bim or Gadd45 mRNAs.
Bcl11b regulates DNA damage and replication stress K Kamimura et al Apoptosis has been considered as a mechanism to eliminate deleterious cells with DNA damages and hence apoptotic phenotype of the KD cells and Bcl11b À/À thymocytes seems to contradict with Bcl11b as a tumor suppressor. However, hyperplastic or dysplastic cells often exhibit apoptotic phenotype together with high mitotic index (Bartkova et al., 2005; Gorgoulis et al., 2005) . Therefore, the apoptotic phenotype may be a reflection of accumulation of DNA damages or a deregulated elevation in cell-cycle progression in those cells. Such precancerous cells probably develop a rapidly progressive tumor phenotype when they acquire the ability to escape apoptosis. Our preliminary analysis showed that apoptosiS prone Bcl11b-deficient cells are capable to develop tumors, as transfer of Bcl11b À/À fetal liver cells into severe combined immunodeficiency mice led to the development of lymphomas at a frequency of four out of 12 cases (data not shown). On the other hand, the present study suggests a concealed function of apoptosis, which positively contributes to tumorigenesis. The activation of caspase-7 resulted in the Claspin cleavage which downregulated phosphorylation of Chk1, consistent with the previous report (Clarke et al., 2005) . This deregulation of Chk1 leading to a high level of Cdc25A is likely to enhance replication-mediated DNA damage accumulation during inappropriate cell cycling, contributing to tumor progression (Walworth et al., 1993; Sanchez et al., 1997; Takai et al., 2000; Lam et al., 2004) . A second possible consequence of apoptosis is a generation of chromosomal translocations through DSBs caused by apoptotic endonucleases, as exemplified in Tel-AML1 translocations (Eguchi-Ishimae et al. 2001). These possibilities may be supported by that selective components of the apoptotic process can be activated, followed by recovery of a normal cellular phenotype in the absence of apoptotic morphology (Alam et al., 1999; Hoeppner et al., 2001; Reddien et al., 2001) .
Finally, it is known that Chk1 downregulation potentiates antimetabolites and topoisomerase inhibitors by depriving the cancer cells of the Chk1 defensive mechanism (Zhou and Bartek, 2004) . Likewise, Bcl11b downregulation sensitizes Jurkat cells to Camptothecin. This suggests that not only Chk1 but also Bcl11b is a potential application target of inhibitors in cancer therapy.
Materials and methods

Mice and genotyping
Bcl11b
þ /À mice of BALB/c background used in this study were maintained under specific pathogen-free conditions in the animal colony of the Niigata University. Bcl11b À/À mice were obtained by mating Bcl11b þ /À mice. Isolation of genomic DNA from brain and thymic lymphomas was carried out by standard protocols. Genotyping of Bcl11b was carried out as described previously (Wakabayashi et al., 2003a; Sakata et al., 2004) . All animal experiments comply to the guidelines by the animal ethics committee for animal experimentation of Niigata University.
Cells
Jurkat cells (p53 deficient) were cultured in Roswell Park Memorial Institute 1640 medium (Sigma, St Louis, MO, USA) containing 10% fetal bovine serum and 100 U/ml penicillin and streptomycin. Two different fragments of 64 nucleotides for siRNA covering the nucleotide positions 646-667 and 1303-1324 (see the Supplementary Figure S2 legend) of human Bcl11b coding region and scramble 21nt-sequence were cloned into pSilencer 2.1-U6 neo (Ambion, Austin, TX, USA). These vectors were transfected into Jurkat cells using DMRIE-C followed by G418 selection. Three and two independent clones (si-1, -2 -3 and si-a, -b) were isolated from the 646-667 region and the 1303-1324 region, respectively, and used. As for the FRSK cells (p53 deficient), the tet-on operator was incorporated into the pSilencer 2.1-U6 neo clone, and this was co-transfected with a hygromycin marker. One of the three independent hygromycin-resistant clones was selected, which showed low spontaneous expression but high inducibility of siRNA expression upon treatment with doxycycline at the dose of 5 mg/ml. The tet-inducible FRSK cells were cultured in the medium containing 10% tet-approved fetal bovine serum Bcl11b regulates DNA damage and replication stress K Kamimura et al (Clontech, Mountain View, CA, USA), 100 mg/ml of G418 and 50 mg/ml of hygromycin.
MTT cell growth assay Jurkat cells were plated in 96-well tissue culture dishes at 5 Â 10 4 cells per well in 100 ml of the medium and treated with and without UV, Camptothecin, or g-ray. FRSK cells were treated in a similar manner in the medium containing doxycycline and in the medium without doxycycline. MTT reagents were added to the cells at the indicated times after the treatment, followed by counting with Premix WST-1 Cell Proliferation Assay System (Takara Inc., Kyoto, Japan).
Synchronization of cells and cell-cycle
Jurkat cells were incubated in the medium containing 0.56 mM thymidine (Sigma) for 18 h. After cultured for 15 h in thymidine-free medium, the cells were again incubated in the same medium for 15 h. Those cells were used for assays after the medium was removed. Six hours after the removal, cells were treated with UV and further incubated for indicated times. After washed in phosphate-buffered saline (PBS) and fixed in 70% ethanol, the cells were stained with propidium iodide, and subjected to analyses by FACSscan flow cytometer (BD Bioscience, San Jose, CA, USA), as described previously (Wakabayashi et al., 2003b) .
Detections of apoptosis
Apoptosis was analysed using Annexin V (BD Biosciences Clontech, Mountain View, CA, USA) by FACSscan flow cytometer (Becton Dickinson) according to the manufacture's protocol.
Fractionation into subcellular components Jurkat cells were suspended in a buffer containing 0.2% NP-40 and fractionated as described (Andegeko et al., 2001) . Cytoplasmic fraction (Cy) was separated from nuclei by lowspeed centrifugation, and the isolated nuclei were resuspended in the buffer containing 0.5% NP-40 and subjected to highspeed centrifugation to obtain soluble nuclear (N) and chromatin-bound (Ch) fractions. The proteins in each fraction Bcl11b regulates DNA damage and replication stress K Kamimura et al were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and duplicate membranes were blotted with antibodies against Bcl11b, Chk1, phosphorylated Chk1 at S317 and at S345 and histone H3.
Western blotting
Thymocytes and culture cells were suspended in PBS and mixed with an equal volume of lysis buffer, 0.125 M Tris-HCl (pH 6.8), 10% sucrose, 10% SDS, 10% 2-ME and 0.004% bromophenol blue. The extract was electrophoresed in 8 and 14% SDS-PAGE gels and blotted onto Hybond membranes (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Antibodies used are listed below. Protein bands were visualized using chemiluminescent detection (ECL plus, Amersham Pharmacia Biotech).
Antibodies
Rabbit anti-Bcl11b-Z antibodies used in these experiments have been described previously (Wakabayashi et al., 2003b 
RT-PCR
Total RNA was prepared from Jurkat cells using the RNA Easy Mini kit (Quiagen, Valencia, CA, USA) according to the protocol recommended by the manufacturer. cDNA was synthesized from 1-5 mg of total RNA with an oligo(dT) primer using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and an aliquot (1-2 of cDNA products) was used for PCR using primers listed below. Multiplex PCR was carried out similarly where glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were always included as a reference. PCR products were separated by electrophoresis in 1% agarose gel and visualized by staining with ethidium bromide.
The primers used in RT-PCR was followed:
GAPDH(forward): GGTCGGAGTCAACGGATTTGGTCG; GAPDH(reverse): CCTCCGACGCCTGCTTCACCAC; p27(forward): TTGCCCGAGTTCTACTACAGACCCC; p27(reverse):
CGAGCTGTTTACGTTTGACG; BclxL(forward):
ATGAACTCTTCCGGGATGG; BclxL(reverse):
TGGATCCAAGGCTCTAGGTG; BIM(forward):
TCCCTACAGACAGAGCCACAAGGT; BIM(reverse):
CAGGTTCAGCCTGCCTCATGGAAG; GADD45(forward): ACGAGGACGACGACAGAGAT; GADD45(reverse): GCAGGATCCTTCCATTGAGA.
The PCR program was: 10 min at 941C, followed by 25 cycles (30 s at 941C, 30 s at 541C, 1 min at 721C), followed by 7 min extension at 721C.
